D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
$728M |
| 3 |
Microsoft
MSFT
|
$524M |
| 4 |
T-Mobile US
TMUS
|
$411M |
| 5 |
Uber
UBER
|
$406M |
Top Sells
| 1 |
Visa
V
|
$567M |
| 2 |
Charles Schwab
SCHW
|
$531M |
| 3 |
Apple
AAPL
|
$484M |
| 4 |
Johnson & Johnson
JNJ
|
$455M |
| 5 |
Accenture
ACN
|
$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
SBA Communications
SBAC
$22B
| $126M | 0.13% |
545,668
+284,737
| +109% | +$66M |
|
102
Cboe Global Markets
CBOE
$24.7B
| $126M | 0.13% |
926,189
+81,839
| +10% | +$11.2M |
|
103
Acadia Pharmaceuticals
ACAD
$4.38B
| $126M | 0.13% |
5,263,078
+362,496
| +7% | +$8.68M |
|
104
Truist Financial
TFC
$60.4B
| $125M | 0.13% |
4,114,098
+752,974
| +22% | +$22.9M |
|
105
CVS Health
CVS
$94B
| $123M | 0.13% |
1,780,925
+309,877
| +21% | +$21.4M |
|
106
Agilent Technologies
A
$35.6B
| $123M | 0.13% |
1,022,568
+117,481
| +13% | +$14.1M |
|
107
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $122M | 0.13% |
922,433
+492,433
| +115% | +$65.4M |
|
108
Starbucks
SBUX
$102B
| $121M | 0.12% |
1,216,969
+338,596
| +39% | +$33.5M |
|
|
DEN
109
DELISTED
Denbury Inc.
DEN
| $120M | 0.12% |
1,396,306
+658,083
| +89% | +$56.8M |
|
|
IMGN
110
DELISTED
Immunogen Inc
IMGN
| $119M | 0.12% |
+6,280,516
| New | +$119M |
|
111
Citigroup
C
$174B
| $118M | 0.12% |
2,555,229
+341,878
| +15% | +$15.7M |
|
112
Advance Auto Parts
AAP
$3.66B
| $117M | 0.12% |
1,661,806
+1,627,993
| +4,815% | +$114M |
|
113
Shopify
SHOP
$181B
| $117M | 0.12% |
1,806,578
+1,533,461
| +561% | +$99.1M |
|
114
Wingstop
WING
$9.16B
| $113M | 0.12% |
564,144
+287,565
| +104% | +$57.6M |
|
115
Option Care Health
OPCH
$4.65B
| $113M | 0.12% |
3,473,023
+2,966,387
| +586% | +$96.4M |
|
116
Incyte
INCY
$16.5B
| $112M | 0.11% |
1,805,514
+931,571
| +107% | +$58M |
|
117
VeriSign
VRSN
$25.5B
| $110M | 0.11% |
484,927
-68,617
| -12% | -$15.5M |
|
118
Burlington
BURL
$18.3B
| $108M | 0.11% |
685,745
-504,435
| -42% | -$79.4M |
|
119
Berkshire Hathaway Class B
BRK.B
$1.08T
| $108M | 0.11% |
315,373
-521,893
| -62% | -$178M |
|
120
Broadcom
AVGO
$1.4T
| $107M | 0.11% |
123,894
-245,495
| -66% | -$213M |
|
121
Adobe
ADBE
$147B
| $107M | 0.11% |
218,039
-458,189
| -68% | -$224M |
|
122
Centene
CNC
$14.5B
| $104M | 0.11% |
1,543,762
+228,781
| +17% | +$15.4M |
|
123
MetLife
MET
$54.1B
| $104M | 0.11% |
1,838,709
+858,718
| +88% | +$48.5M |
|
124
RH
RH
$4.23B
| $103M | 0.11% |
312,618
+308,568
| +7,619% | +$102M |
|
125
Carvana
CVNA
$50.6B
| $101M | 0.1% |
3,912,643
+3,853,226
| +6,485% | +$99.9M |
|